Investigator Site #22 — Butler, Pennsylvania

Investigator Site #22 is a clinical research site located in Butler, Pennsylvania, United States 16001.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Investigator Site #22 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Focal Segmental Glomerulosclerosis.

Sponsors: Akebia Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Butler

Browse all research sites in Pennsylvania · View every site in Butler

• Butler Memorial Hospital
• UPMC Hillman Cancer Center at Butler Health System
• Research Site
• Tesla MedBed Center at Butler-PA
• Tesla BioHealing Medical Center in Butler-PA
• Tesla MedBed Center, 139 Pittsburgh Road, Butler, PA 16001
• Tesla BioHealing Wellness Hotel - Butler-PA
• Medical Center Clinic-Butler Office
• UPMC-Butler
• UPMC CancerCenters Butler
• SouthWestern Pennsylvania Cardiovascular Associates

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigator Site #22?

Investigator Site #22 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigator Site #22 conducted?

Investigator Site #22 has 1 clinical trials on record, with 1 currently active. Their work covers Focal Segmental Glomerulosclerosis.

Is Investigator Site #22 accredited by Crixeo Clinical Trials?

Investigator Site #22 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigator Site #22?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.